Stephen Forman
Director of the Hematologic Malignancies Research Institute at City of Hope · City of Hope National Medical Center
Credentials: · · ·
History
- 1974–1977
Internal Medicine
Research
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
Case report · New England Journal of Medicine · 2016 · 1,520 citations
Blood · 2000 · 1,319 citations
The Lancet Oncology · 2015 · 1,047 citations
141 papers
- AS
136 papers · 1 as a fellow
- VP
116 papers
114 papers
109 papers
- AN
106 papers
89 papers · 13 as a resident
- DS
88 papers
Grants
- 2022–2028
National Cancer Institute · R01
PI · $3.2M · Beckman Research Institute/City of Hope
- 2004–2025
National Cancer Institute · P50
Contact PI · $35.5M · Beckman Research Institute/City of Hope
- 1997–2023
National Cancer Institute · P30
Project lead · $277.9K · Beckman Research Institute/City of Hope
- 2015–2018
Image-Guided Irradiation Safely Intensifies HSCT Regimen for Refractory Leukemia
National Cancer Institute · R01
Contact PI · $782.9K · Beckman Research Institute/City of Hope
Clinical trials
- 2002–2011
Principal investigator · Completed · Phase 1
City of Hope Medical Center
- 2011–2016
Study chair · Completed · Phase 2
University of Michigan Rogel Cancer Center
- 1995–2003
Study chair · Completed · Phase 2
SWOG Cancer Research Network
- 2001–2006
Blood and Marrow Transplant Clinical Research Network
Completed
National Heart, Lung, and Blood Institute (NHLBI)